2025
SJR Q1
JCR Q2 · 3,7
35 matched articles
SCIE
Journal detail
Clinical Therapeutics
- Publisher
- Elsevier Inc.
- Country
- United States · Northern America
- Type
- journal
- ISSN
-
014929181879114X
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 1,041
- Quartile Q1
- H-Index 158
- Cites/doc 2,89
- Docs (3y) 538
- Cites (3y) 1.768
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 3,7
- 5Y JIF 3,9
- JCI 0,71
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Pharmacology Q1
- Pharmacology (medical) Q1
Areas
- Medicine
- Pharmacology, Toxicology and Pharmaceutics
WoS categories
- Pharmacology & Pharmacy
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q2 | 1,041 | 3,7 | 3,9 | 0,71 | Q2 | 158 |
| 2024 | Q1 | Q2 | 0,978 | 3,6 | 3,3 | 0,73 | Q2 | 153 |
| 2023 | Q1 | Q2 | 0,875 | 3,2 | 3 | 0,73 | Q2 | 153 |
| 2022 | Q1 | Q3 | 0,896 | 3,2 | 3,2 | 0,74 | Q2 | 153 |
| 2021 | Q2 | Q2 | 0,824 | 3,6 | 3,9 | 0,72 | Q2 | 153 |
| 2020 | Q2 | Q3 | 0,925 | 3,4 | 3,8 | 0,81 | Q2 | 153 |
| 2019 | Q1 | Q2 | 0,981 | 3,1 | 3,2 | 0,88 | Q2 | 153 |
| 2018 | — | Q2 | — | 2,9 | 3,1 | 0,95 | Q2 | — |
| 2017 | Q1 | Q2 | 1,151 | 3,2 | 3 | 0,98 | Q2 | 153 |
| 2016 | Q1 | Q2 | 1,19 | 2,9 | 2,9 | — | — | 153 |
| 2015 | Q1 | Q2 | 1,053 | 2,9 | 2,6 | — | — | 153 |
| 2014 | Q2 | Q2 | 0,976 | 2,7 | 2,6 | — | — | 153 |
| 2013 | Q1 | Q2 | 0,977 | 2,6 | 2,6 | — | — | 153 |
| 2012 | Q1 | Q2 | 0,976 | 2,2 | 2,7 | — | — | 153 |
| 2011 | Q1 | Q2 | 1,019 | 2,3 | 3 | — | — | 153 |
| 2010 | Q1 | Q2 | 1,068 | 2,6 | 3,1 | — | — | 153 |
| 2009 | — | Q2 | — | 3,2 | 3,4 | — | — | — |
| 2008 | — | Q2 | — | 3,1 | 3,3 | — | — | — |
| 2007 | — | Q2 | — | 3,3 | 3,3 | — | — | — |
| 2006 | — | Q2 | — | 2,9 | — | — | — | — |
| 2005 | — | Q2 | — | 3 | — | — | — | — |
| 2004 | — | Q1 | — | 3 | — | — | — | — |
| 2003 | — | Q2 | — | 2,7 | — | — | — | — |
| 2002 | — | Q1 | — | 3,1 | — | — | — | — |
| 2001 | — | Q1 | — | 2,7 | — | — | — | — |
| 2000 | — | Q2 | — | 2,1 | — | — | — | — |
| 1999 | — | Q2 | — | 2 | — | — | — | — |
| 1998 | — | Q2 | — | 1,5 | — | — | — | — |
| 1997 | — | Q3 | — | 1 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 120/356 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 103/352 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 124/354 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 146/278 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 136/279 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 141/276 |
| 2019 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 104/271 |
| 2018 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 108/267 |
| 2017 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 81/261 |
| 2016 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 93/257 |
| 2015 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 80/255 |
| 2014 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 100/255 |
| 2013 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 105/256 |
| 2012 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 129/261 |
| 2011 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 121/261 |
| 2010 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 108/252 |
| 2009 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 65/237 |
| 2008 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 67/219 |
| 2007 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 52/205 |
| 2006 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 55/199 |
| 2005 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 49/193 |
| 2004 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 45/187 |
| 2003 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 47/185 |
| 2002 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 35/188 |
| 2001 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | — | 36/186 |
| 2000 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 51/181 |
| 1999 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 48/175 |
| 1998 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 62/178 |
| 1997 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 92/157 |